NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War
In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant
DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination
NCI Intends To Extend OSCC Two More Years
Prostate Ultrasound Markers Concepts Approved by BSC
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final









